Cannapharmarx (CPMD) has released an update.
CannaPharmaRx has announced the appointment of Dean Medwid as its new CEO, taking over from Domenic Colvin to steer the company through an anticipated period of rapid growth. Medwid brings over three decades of experience, including notable achievements in brand development, strategic partnerships, and operational efficiency, to CannaPharmaRx. The company aims to fortify its position in cannabis production by leveraging Medwid’s track record of driving growth and his recent successful ventures in the cannabis retail sector.
For further insights into CPMD stock, check out TipRanks’ Stock Analysis page.